Clinical Predictors of Worsening in Non-severe Acute Cholangitis

Objective Risk factors for progression from non-severe to severe acute cholangitis (AC) remain unclear. This study aimed to identify predictors of disease progression with a particular focus on the prognostic nutritional index (PNI). Materials and methods We retrospectively analyzed 239 patients with Grade I or II AC who underwent endoscopic biliary drainage within 24 h of hospital presentation. The patients were classified into 2 groups: progression (n = 18) and non-progression (n = 221). The clinical characteristics were compared between the two groups. Results The progression group had a higher proportion of Grade II AC (83.3% vs. 47.5%, p = 0.006) and received immunosuppressive therapy more frequently (27.8% vs. 5.9%, p = 0.006) but had a lower PNI (36.67 vs. 39.81, p = 0.003) than the non-progression group. The proportion of patients with low PNI (<38) was significantly higher in the progression group than in the non-progression group (66.6% vs. 37.6%, p = 0.023). In addition, the mortality rate was significantly higher in the progression group than in the non-progression group (11.1% vs. 0.9%, p = 0.029). Conclusion Progression to severe AC may be associated with Grade II AC, immunosuppressive therapy, and a low PNI. Even after early biliary drainage, patients presenting with these conditions require close clinical monitoring.

Authors

Institutions

Publication Details

Journal
Internal Medicine
Published
2025-01-01
DOI
https://doi.org/10.2169/internalmedicine.6355-25
Citations
1
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Predictors of Worsening in Non-severe Acute Cholangitis

Takaaki Yoshimoto, Koichiro Mandai, Koji Uno, Shiho Nakamura et al.
1 citations
Internal Medicine
Gallbladder and Bile Duct Disorders
1.52
article

Clinical Predictors of Worsening in Non-severe Acute Cholangitis

Takaaki Yoshimoto, Koichiro Mandai, Koji Uno, Shiho Nakamura, Takato Inoue
article en
1 citations

Abstract

Objective Risk factors for progression from non-severe to severe acute cholangitis (AC) remain unclear. This study aimed to identify predictors of disease progression with a particular focus on the prognostic nutritional index (PNI). Materials and methods We retrospectively analyzed 239 patients with Grade I or II AC who underwent endoscopic biliary drainage within 24 h of hospital presentation. The patients were classified into 2 groups: progression (n = 18) and non-progression (n = 221). The clinical characteristics were compared between the two groups. Results The progression group had a higher proportion of Grade II AC (83.3% vs. 47.5%, p = 0.006) and received immunosuppressive therapy more frequently (27.8% vs. 5.9%, p = 0.006) but had a lower PNI (36.67 vs. 39.81, p = 0.003) than the non-progression group. The proportion of patients with low PNI (<38) was significantly higher in the progression group than in the non-progression group (66.6% vs. 37.6%, p = 0.023). In addition, the mortality rate was significantly higher in the progression group than in the non-progression group (11.1% vs. 0.9%, p = 0.029). Conclusion Progression to severe AC may be associated with Grade II AC, immunosuppressive therapy, and a low PNI. Even after early biliary drainage, patients presenting with these conditions require close clinical monitoring.

Internal Medicine
Kyoto first Red Cross hospital (JP)
Openalex Percentile: Top 13%
Gallbladder and Bile Duct Disorders
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.